Name |
Rapibloc 20 mg/2 ml koncentrat za otopinu za injekciju |
Marketing Authorisation Number |
HR-H-555892936 |
Active Substance |
landiololklorid |
Composition |
svaki ml koncentrata sadrži 10 mg landiololklorida što odgovara 9,35 mg landiolola |
Pharmaceutical Form |
koncentrat za otopinu za injekciju |
Manufacturer |
AOP Orphan Pharmaceuticals GmbH, Beč, Austrija |
Marketing Authorisation Holder |
Amomed Pharma GmbH, Leopold-Ungar-Platz 2, Beč, Austrija |
Marketing Authorisation Date |
16.06.2021 |
MA Period of Validity |
unlimited |
Classification Number |
UP/I-530-09/20-02/131 |
Registration Number |
381-12-01/154-21-02 |
Prescription |
na recept |
Type of prescription |
ograničeni recept
|
Distribution |
u ljekarni |
Advertising to general public |
zabranjeno |
ATC Code |
C07AB14 |
Medicinal product marketed in the Croatia |
Ne |
SmPC |
download |
PL |
download |
Public Assessment Report |
download
|